Camelia pharmacy chain has been acquired by Medigate Management UAB
CGP Management UAB has sold the Camelia pharmacy chain (UAB Nemuno vaistinė and subsidiaries) to Medigate Management UAB.
UAB Nemuno vaistinė, operating under the brand name Camelia, is the leading pharmacy chain in Lithuania. The group carries out retail and wholesale trade in pharmaceuticals, food supplements, medical devices and cosmetics. Camelia’s pharmacy chain includes a countrywide network of approximately 300 own and 30 franchise outlets and manages one of the leading online pharmacies in Lithuania. Besides pharmacy retail and wholesale, the group is also involved in the development of pharmaceutical and nutraceutical products under its own brand names (private label).
Medigate Management UAB is a private investment holding company owned by Mr. Petras Bartkus (a minority shareholder in Camelia before the transaction). Medigate Management owns UAB Medigate, a developer and wholesaler of food supplements, medical devices and cosmetics in Lithuania.
CGP Management UAB is a private holding company owned by the founder of the Camelia pharmacy chain.
Oaklins’ team in Lithuania acted as the sole financial advisor to CGP Management on the sale of the Camelia pharmacy chain to Medigate Management.
Talk to the deal team
Related deals
Nuzoa has acquired Dinazoo
Spanish private equity-backed Nuzoa, a prominent animal health distributor in Spain, has acquired Dinazoo. This acquisition marks one of the first steps in Nuzoa’s international expansion. It will strengthen Nuzoa’s relationships with key clients who also operate in the Portuguese market, along with its suppliers. This agreement will enhance both companies’ presence in the Portuguese market by gaining access to more advanced technology and expanding their portfolio in key areas of the business.
Learn moreNuzoa has acquired Siloal
Spanish private equity-backed Nuzoa, a prominent animal health distributor in Spain, has acquired Siloal. This acquisition marks one of the first steps in Nuzoa’s international expansion. It will strengthen Nuzoa’s relationships with key clients who also operate in the Portuguese market, along with its suppliers. This agreement will enhance both companies’ presence in the Portuguese market by gaining access to more advanced technology and expanding their portfolio in key areas of the business.
Learn moreVivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.
Learn more